Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

91

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Tachykinin signaling in the right parabrachial nucleus mediates early-phase neuropathic pain development

Tachykinin signaling in the right parabrachial nucleus ...

92

Monocyte-derived IL-10 drives sex differences in pain duration

Monocyte-derived IL-10 drives sex differences in pain d...

17

Macrophage-induced enteric neurodegeneration leads to motility impairment during gut inflammation

Macrophage-induced enteric neurodegeneration leads to m...

76